Smooth Muscle Cells Orchestrate the Endothelial Cell Response to Flow and Injury
Open Access
- 25 May 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cell Metabolism
- Vol. 121 (20), 2192-2199
- https://doi.org/10.1161/CIRCULATIONAHA.109.877282
Abstract
Background— Local modulation of vascular mammalian target of rapamycin (mTOR) signaling reduces smooth muscle cell (SMC) proliferation after endovascular interventions but may be associated with endothelial cell (EC) toxicity. The trilaminate vascular architecture juxtaposes ECs and SMCs to enable complex paracrine coregulation but shields SMCs from flow. We hypothesized that flow differentially affects mTOR signaling in ECs and SMCs and that SMCs regulate mTOR in ECs. Methods and Results— SMCs and/or ECs were exposed to coronary artery flow in a perfusion bioreactor. We demonstrated by flow cytometry, immunofluorescence, and immunoblotting that EC expression of phospho-S6 ribosomal protein (p-S6RP), a downstream target of mTOR, was doubled by flow. Conversely, S6RP in SMCs was growth factor but not flow responsive, and SMCs eliminated the flow sensitivity of ECs. Temsirolimus, a sirolimus analog, eliminated the effect of growth factor on SMCs and of flow on ECs, reducing p-S6RP below basal levels and inhibiting endothelial recovery. EC p-S6RP expression in stented porcine arteries confirmed our in vitro findings: Phosphorylation was greatest in ECs farthest from intact SMCs in metal stented arteries and altogether absent after sirolimus stent elution. Conclusions— The mTOR pathway is activated in ECs in response to luminal flow. SMCs inhibit this flow-induced stimulation of endothelial mTOR pathway. Thus, we now define a novel external stimulus regulating phosphorylation of S6RP and another level of EC-SMC crosstalk. These interactions may explain the impact of local antiproliferative delivery that targets SMC proliferation and suggest that future stents integrate design influences on flow and drug effects on their molecular targets.This publication has 45 references indexed in Scilit:
- A Cytosolic Homomerization and a Modulatory Domain within STIM1 C Terminus Determine Coupling to ORAI1 ChannelsPublished by Elsevier BV ,2009
- Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive RemodelingPublished by Elsevier BV ,2009
- Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in MiceCirculation Research, 2009
- Thrombus causes fluctuations in arterial drug delivery from intravascular stentsJournal of Controlled Release, 2008
- Luminal flow patterns dictate arterial drug deposition in stent-based deliveryJournal of Controlled Release, 2008
- Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHLNature, 2008
- Endothelial Injury Induces Vascular Smooth Muscle Cell Proliferation in Highly Localized Regions of a Direct Contact Co-culture SystemCell Biochemistry and Biophysics, 2008
- Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatmentDrug Resistance Updates, 2008
- Intravascular drug release kinetics dictate arterial drug deposition, retention, and distributionJournal of Controlled Release, 2007
- Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLBlood, 2006